Literature DB >> 31794334

Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.

Arnethea L Sutton1, Alejandra Hurtado-de-Mendoza2, John Quillin3, Lisa Rubinsak4, Sarah M Temkin5, Tamas Gal6, Vanessa B Sheppard1,7.   

Abstract

Purpose: Genetic counseling (GC) provides critical risk prediction information to women at-risk of carrying a genetic alternation; yet racial/ethnic and socioeconomic disparities persist with regard to GC uptake. This study examined patterns of GC uptake after a referral in a racially diverse population. Materials and
Methods: In an urban academic medical center, medical records were reviewed between January 2016 and December 2017 for women who were referred to a genetic counselor for hereditary breast and ovarian cancer. Study outcomes were making an appointment (yes/no) and keeping an appointment. We assessed sociodemographic factors and clinical factors. Associations between factors and the outcomes were analyzed using chi square, and logistic regression was used for multivariable analysis.
Results: A total of 510 women were referred to GC and most made appointments. More than half were white (55.3%) and employed (53.1%). No significant associations were observed between sociodemographic factors and making an appointment. A total of 425 women made an appointment and 268 kept their appointment. Insurance status (p = 0.003), marital status (p = 0.000), and work status (p = 0.039) were associated with receiving GC. In the logistic model, being married (odds ratio [OR] 2.119 [95% confidence interval, CI 1.341-3.347] p = 0.001) and having insurance (OR 2.203 [95% CI 1.208-4.016] p = 0.021) increased the likelihood of receiving counseling. Conclusions: Racial disparities in GC uptake were not observed in this sample. Unmarried women may need additional support to obtain GC. Financial assistance or other options need to be discussed during navigation as a way to lessen the disparity between women with insurance and those without.

Entities:  

Keywords:  BRCA 1/2; disparities; genetic counseling; hereditary breast and ovarian cancer; navigation

Mesh:

Year:  2019        PMID: 31794334      PMCID: PMC7462013          DOI: 10.1089/jwh.2019.7984

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  30 in total

1.  A pilot study of spatial patterns in referrals to a multicentre cancer genetics service.

Authors:  Vanessa Tempest; Gary Higgs; Kevin McDonald; Rachel Iredale; Tony Bater; Jonathon Gray
Journal:  Community Genet       Date:  2005

2.  Awareness and acceptability of population-based screening for pathogenic BRCA variants: Do race and ethnicity matter?

Authors:  Lisa A Rubinsak; Annette Kleinman; John Quillin; Sarah W Gordon; Stephanie A Sullivan; Arnethea L Sutton; Vanessa B Sheppard; Sarah M Temkin
Journal:  Gynecol Oncol       Date:  2019-06-22       Impact factor: 5.482

3.  Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites.

Authors:  Alice S Whittemore; Gail Gong; Esther M John; Valerie McGuire; Frederick P Li; Kimberly L Ostrow; Richard Dicioccio; Anna Felberg; Dee W West
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

Review 4.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Laurie Hoyt Huffman; Rongwei Fu; Emily L Harris
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

5.  Association of patient navigation with care coordination in an Lynch syndrome screening program.

Authors:  Susan Miesfeldt; W Gregory Feero; Frances L Lucas; Karen Rasmussen
Journal:  Transl Behav Med       Date:  2018-05-23       Impact factor: 3.046

Review 6.  The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials.

Authors:  Sobia F Ali-Faisal; Tracey J F Colella; Naomi Medina-Jaudes; Lisa Benz Scott
Journal:  Patient Educ Couns       Date:  2016-10-17

7.  Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement.

Authors:  Maria Teresa Ricci; Stefania Sciallero; Serafina Mammoliti; Viviana Gismondi; Marzena Franiuk; Paolo Bruzzi; Liliana Varesco
Journal:  Public Health Genomics       Date:  2015-06-24       Impact factor: 2.000

Review 8.  Molecular pathogenesis of bilateral breast cancer.

Authors:  Evgeny N Imyanitov; Kaido P Hanson
Journal:  Cancer Lett       Date:  2003-02-28       Impact factor: 8.679

9.  A survey of genetic counselors' strategies for addressing ethical and professional challenges in practice.

Authors:  Matthew A Bower; Patricia McCarthy Veach; Dianne M Bartels; Bonnie S LeRoy
Journal:  J Genet Couns       Date:  2002-06       Impact factor: 2.537

10.  Psychological adjustment among partners of women at high risk of developing breast/ovarian cancer.

Authors:  Shab Mireskandari; Kerry A Sherman; Bettina Meiser; Alan J Taylor; Margaret Gleeson; Lesley Andrews; Katherine M Tucker
Journal:  Genet Med       Date:  2007-05       Impact factor: 8.822

View more
  2 in total

1.  Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system.

Authors:  Kristin R Muessig; Jamilyn M Zepp; Erin Keast; Elizabeth E Shuster; Ana A Reyes; Briana Arnold; Chalinya Ingphakorn; Marian J Gilmore; Tia L Kauffman; Jessica Ezzell Hunter; Sarah Knerr; Heather S Feigelson; Katrina A B Goddard
Journal:  Hered Cancer Clin Pract       Date:  2022-02-10       Impact factor: 2.857

2.  Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.

Authors:  Rita Kukafka; Samuel Pan; Thomas Silverman; Tianmai Zhang; Wendy K Chung; Mary Beth Terry; Elaine Fleck; Richard G Younge; Meghna S Trivedi; Julia E McGuinness; Ting He; Jill Dimond; Katherine D Crew
Journal:  JAMA Netw Open       Date:  2022-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.